GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Market Cap

Ectin Research AB (XSAT:ECTIN B) Market Cap : kr8.12 Mil (As of Jun. 10, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ectin Research AB's share price for the quarter that ended in Mar. 2024 was kr0.646. Ectin Research AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 12.69 Mil. Therefore, Ectin Research AB's market cap for the quarter that ended in Mar. 2024 was kr8.20 Mil.

Ectin Research AB's quarterly market cap declined from Sep. 2023 (kr5.69 Mil) to Dec. 2023 (kr3.93 Mil) but then increased from Dec. 2023 (kr3.93 Mil) to Mar. 2024 (kr8.20 Mil).

Ectin Research AB's annual market cap increased from Aug. 2020 (kr0.00 Mil) to Dec. 2022 (kr10.53 Mil) but then declined from Dec. 2022 (kr10.53 Mil) to Dec. 2023 (kr3.93 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ectin Research AB's Enterprise Value for Today is kr4.96 Mil.


Ectin Research AB Market Cap Historical Data

The historical data trend for Ectin Research AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Market Cap Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Market Cap
- - 10.53 3.93

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.29 6.22 5.69 3.93 8.20

Competitive Comparison of Ectin Research AB's Market Cap

For the Biotechnology subindustry, Ectin Research AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ectin Research AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's Market Cap falls into.



Ectin Research AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ectin Research AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr0.31*12.6903
=kr3.93

Ectin Research AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=kr0.646*12.6903
=kr8.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB  (XSAT:ECTIN B) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Ectin Research AB Market Cap Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines